Eli Lilly and Company (LLY)
NYSE · Healthcare · Drug Manufacturers - General
Eli Lilly and Company is a Healthcare company with a market capitalization of $1.04T, a trailing P/E ratio of 39.1, and a dividend yield of 0.53%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $8.55 | $6.79 | +25.9% |
| Q4 2025 | February 4, 2026 | $7.54 | $7.17 | +5.2% |
| Q3 2025 | October 30, 2025 | $7.02 | $5.89 | +19.2% |
| Q2 2025 | August 7, 2025 | $6.31 | $5.61 | +12.5% |
| Q1 2025 | May 1, 2025 | $3.34 | $3.46 | -3.5% |
| Q4 2024 | February 6, 2025 | $5.32 | $5.07 | +5.0% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 10,278,892 | 1.14% | 4.1 | +9.9% |
| June 30, 2026 | 9,353,153 | 1.04% | 2.6 | -3.2% |
| June 15, 2026 | 9,662,739 | 1.08% | 3.0 | -1.4% |
| May 29, 2026 | 9,795,475 | 1.09% | 3.0 | +16.2% |
| May 15, 2026 | 8,430,505 | 0.94% | 2.5 | +7.2% |
| April 30, 2026 | 7,862,175 | 0.87% | 2.2 | -3.1% |
| April 15, 2026 | 8,114,678 | 0.90% | 2.9 | +5.3% |
| March 31, 2026 | 7,704,068 | 0.86% | 2.5 | +12.1% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Eli Lilly and Company's market cap?
As of August 13, 2026, Eli Lilly and Company (LLY) has a market capitalization of $1.04T.
What is Eli Lilly and Company's P/E ratio?
Eli Lilly and Company trades at a trailing price-to-earnings (P/E) ratio of 39.1. Its forward P/E is 32.1.
Does Eli Lilly and Company pay a dividend?
Yes — Eli Lilly and Company pays a dividend yielding 0.53%, an annual payout of $6.46 per share.
What sector is LLY in?
Eli Lilly and Company is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is Eli Lilly and Company's short interest?
As of the July 15, 2026 FINRA settlement, 10,278,892 LLY shares were sold short, or 1.14% of shares outstanding. Days to cover: 4.1. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Eli Lilly and Company's revenue?
In its latest reported fiscal year (ending December 31, 2025), Eli Lilly and Company reported revenue of $65.18B and net income of $20.64B.
Ask your own questions about LLY
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.